-
Evolution of Body Composition and Associations to Glucose Metabolism During the First Year After Kidney Transplantation.
-
Evolution of Donor Nephrectomy: Long-Term Outcomes with Four Different Techniques Between 1963 and 2014 at a Single Institution.
-
Evolving to Everolimus: A Safe and Effective Option for Pancreas Transplant.
-
Ex Situ Perfusion of a Human Limb for 24 Hours.
-
Ex Vivo Expansion of Human Alloantigen-Reactive Regulatory T Cells Using Monocyte-Derived Dendritic Cells versus CD40L-Stimulated B Cells.
-
Ex Vivo Perfusion of Porcine Forelimbs to Prolong Allowable Ischemia Time.
-
Ex-Vivo Normothermic Perfusion (EVNP) Attenuation of Kidney Ischemia-Reperfusion Injury (IRI): A Proposed Mechanism.
-
Ex-Vivo Normothermic Perfusion for Assessment of High Risk Deceased Donor Kidneys for Transplantation.
-
Examining the Risk for Post-Transplant Viral Infections and Lymphoproliferative Disorder (PTLD) in Kidney Transplant Patients (Pts) Receiving Calcineurin Inhibitor-Based Immunosuppression (CNI-IS) Compared to Belatacept (CTLA4Ig).
-
Excellent Results of Living-Related Renal Transplant Recipients Treated with High-Dose Mizoribine – Comparison of Taclorimus with CsA for Two Years Result by a Japanese Multicenter Study.
- « Previous Page
- 1
- …
- 58
- 59
- 60
- 61
- 62
- …
- 180
- Next Page »